Login / Signup

Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials.

Kristin Kaasen JørgensenGuro L GollJoe SextonNils BolstadInge C OlsenØivind AsakIngrid P BersetIngrid M BlomgrenKatrine DvergsnesJon FlorholmenSvein O FrigstadMagne HenriksenJon HagforsGert Huppertz-HaussEspen A HaavardsholmRolf A KlaasenBjørn MoumGeir NorabergUlf PrestegårdJan H RydningLiv SagatunKathrine A SeebergRoald TorpCecilia VoldDavid J WarrenCarl M YstrømKnut E A LundinTore KvienProf Jørgen Jahnsen
Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2021)
ClinicalTrials.gov, number NCT02148640.
Keyphrases
  • image quality
  • dual energy
  • computed tomography
  • contrast enhanced
  • ulcerative colitis
  • positron emission tomography
  • magnetic resonance imaging